A Cost-Utility Analysis of Magnetic Resonance (MR) Guided Brachytherapy versus Two Dimensional and Computed Tomography (CT) Guided Brachytherapy for Locally Advanced Cervical Cancer
and Purpose: The standard treatment for locally advanced cervical cancer is external beam radiotherapy and concurrent cisplatin followed by brachytherapy. Traditionally, two-dimensional (2DBT) or computed tomography guided (CTgBT) brachytherapy has been used, but magnetic resonance guided brachytherapy (MRgBT) improves clinical outcomes and has become the new standard of care. This cost-utility analysis (CUA) was undertaken to compare MRgBT to CTgBT and 2DBT.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: J. Perdrizet, D. D ’Souza, J. Skliarenko, M. Ang, L. Barbera, E. Gutierrez, A. Ravi, K. Tanderup, P. Warde, K.K.W. Chan, W. Isaranuwatchai, M. Milosevic Source Type: research
More News: Biology | Brachytherapy | Cancer | Cancer & Oncology | Cervical Cancer | CT Scan | External Beam Therapy | Physics | Radiology